Chongqing Taiji Industry (Group) Co Ltd
600129
Company Profile
Business description
Chongqing Taiji Industry (Group) Co Ltd is a China-based company engaged in the production and sales of Chinese and Western medicines. It is also engaged in the cultivation of medicinal herbs. Its products mainly include capsules, syrup, oral liquid, lyophilized series, tablets, infusion series, and injections. The company mainly conducts its business in domestic and overseas markets.
Contact
No. 18, Hengshan East Road
Yubei District
Chongqing401123
CHNT: +86 2372800072
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
10,864
Stocks News & Analysis
stocks
Cheap ASX share may have more room to run
Shares are cheap despite rebounding share price, yet risks remain.
stocks
ASX listed media giant drives strong earnings growth
Digital growth drives earnings beat for media share.
stocks
ASX real estate platform outperforms yet questions remain
Valuation remains a key concern despite strong August reporting.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,424.10 | 13.30 | -0.14% |
| CAC 40 | 8,704.15 | 10.78 | -0.12% |
| DAX 40 | 26,408.48 | 89.03 | 0.34% |
| Dow JONES (US) | 54,036.93 | 151.83 | 0.28% |
| FTSE 100 | 10,874.20 | 26.89 | -0.25% |
| HKSE | 25,937.49 | 269.46 | 1.05% |
| NASDAQ | 26,690.62 | 342.26 | 1.30% |
| Nikkei 225 | 66,970.22 | 1,363.51 | 2.08% |
| NZX 50 Index | 13,888.24 | 64.11 | 0.46% |
| S&P 500 | 7,757.64 | 47.68 | 0.62% |
| S&P/ASX 200 | 9,232.60 | 17.00 | -0.18% |
| SSE Composite Index | 3,966.59 | 26.56 | 0.67% |